Literature DB >> 3312284

Proposed immunopathogenic factors associated with progression from human immunodeficiency virus seropositivity to clinical disease.

D J Mock1, N J Roberts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312284      PMCID: PMC269348          DOI: 10.1128/jcm.25.10.1817-1821.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  45 in total

1.  Macrophage-lymphocyte clusters in lymph nodes: a possible substrate for cellular interactions in the immune response.

Authors:  A G Farr; P P De Bruyn
Journal:  Am J Anat       Date:  1975-10

Review 2.  AIDS--an immunologic reevaluation.

Authors:  M Seligmann; L Chess; J L Fahey; A S Fauci; P J Lachmann; J L'Age-Stehr; J Ngu; A J Pinching; F S Rosen; T J Spira
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

3.  Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes.

Authors:  R A Moscicki; E P Amento; S M Krane; J T Kurnick; R B Colvin
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

4.  Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage.

Authors:  G S Wood; N L Warner; R A Warnke
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

5.  Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats.

Authors:  O Narayan; J S Wolinsky; J E Clements; J D Strandberg; D E Griffin; L C Cork
Journal:  J Gen Virol       Date:  1982-04       Impact factor: 3.891

6.  Acquired immunodeficiency syndrome in Rwanda.

Authors:  P Van de Perre; D Rouvroy; P Lepage; J Bogaerts; P Kestelyn; J Kayihigi; A C Hekker; J P Butzler; N Clumeck
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

7.  Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.

Authors:  G M Shaw; B H Hahn; S K Arya; J E Groopman; R C Gallo; F Wong-Staal
Journal:  Science       Date:  1984-12-07       Impact factor: 47.728

8.  Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome.

Authors:  C Harris; C B Small; R S Klein; G H Friedland; B Moll; E E Emeson; I Spigland; N H Steigbigel
Journal:  N Engl J Med       Date:  1983-05-19       Impact factor: 91.245

9.  Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

Authors:  Y Koyanagi; S Miles; R T Mitsuyasu; J E Merrill; H V Vinters; I S Chen
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

10.  Macrophage-lymphocyte clusters in the immune response to soluble protein antigen in vitro.

Authors:  O Werdelin; O Braendstrup; E Pedersen
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Contemporary issues: diseases with a food vector.

Authors:  D L Archer; F E Young
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

2.  Augmentation of lymphocyte and macrophage proliferation by caprine arthritis-encephalitis virus contributes to the development of progressive arthritis.

Authors:  K L Banks; M A Jutila; C A Jacobs; F H Michaels
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens.

Authors:  M Denis; E Ghadirian
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

4.  Influenza Virus Infection of Human Lymphocytes Occurs in the Immune Cell Cluster of the Developing Antiviral Response.

Authors:  David J Mock; Mark W Frampton; Joan E Nichols; Frank M Domurat; Denise J Signs; Norbert J Roberts
Journal:  Viruses       Date:  2018-08-10       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.